As of 2026-04-08, the Relative Valuation of SAGE Therapeutics Inc (SAGE) is (108.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.68 USD, the upside of SAGE Therapeutics Inc based on Relative Valuation is -1349.2%.
The range of the Relative Valuation is (103.82) - (118.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 26.2x | 23.8x |
| Forward P/E multiples | 21.0x - 24.6x | 21.4x |
| Fair Price | (103.82) - (118.21) | (108.43) |
| Upside | -1296.1% - -1461.9% | -1349.2% |
| Date | P/E |